Lung Cancer in a Rural Area of China: Rapid Rise in Incidence and Poor Improvement in Survival |
Yang, Juan
(Qidong Liver Cancer Institute / Qidong People's Hospital)
Zhu, Jian (Qidong Liver Cancer Institute / Qidong People's Hospital) Zhang, Yong-Hui (Qidong Liver Cancer Institute / Qidong People's Hospital) Chen, Yong-Sheng (Qidong Liver Cancer Institute / Qidong People's Hospital) Ding, Lu-Lu (Qidong Liver Cancer Institute / Qidong People's Hospital) Kensler, Thomas W (Department of Pharmacology & Chemical Biology, University of Pittsburgh) Chen, Jian-Guo (Qidong Liver Cancer Institute / Qidong People's Hospital) |
1 | Brenner H, Stegmaier C, Ziegler H (2005). Long-term survival of cancer patients in Germany achieved by the beginning of the third millenium. Ann Oncol, 16, 981-6. DOI |
2 | Chen JG, Kensler TW (2014). Changing rates for liver and lung cancers in Qidong, China. Chem Res Toxicol, 27, 3-6. DOI |
3 | Chen JG, Li WG, Shen ZC, et al (1998). Population-based cancer survival in Qidong, China. In: Sankaranarayanan R, Black R, Parkin DM, editors. Cancer Survival in Developing Countries. IARC Sci Pub No. 145. Lyon: IARC, 27-35. |
4 | Chen JG, Peto R, Sun ZT, et al (1991). Feasibility of a prospective study of smoking and mortality in Qidong, China. In: O'Neill IK, Chen J, Bartsch H, eds. Relevance to Human Cancer of N-Nitroso Compounds, Tobacco Smoke and Mycotoxins. IARC Sci Publ No. 105, Lyon: IARC, 502-6. |
5 | Chen JG, Zhu J, Parkin DM, et al (2006). Trends in the incidence of cancer in Qidong, China, 1978-2002. Int J Cancer, 119, 1447-54. DOI |
6 | Chen JS, Xiao JR, Chen ZC, et al (2000). Relative survival rate analysis of malignant cancers patient in Changle city. Chin Cancer, 9, 535-6. |
7 | Chen W, Zheng R, Zeng H, et al (2015). Annual report on status of cancer in China, 2011. Chin J Cancer Res, 27, 2-12. |
8 | Chen W, Zheng R, Zhang S, et al (2014). Annual report on status of cancer in China, 2010. Chin J Cancer Res, 26, 48-58. |
9 | Chen Z, Luo Q, Jian H, et al (2013). Long-term results of a randomized controlled trial evaluating preoperative chemotherapy in resectable non-small cell lung cancer. Onco Targets Ther, 6, 645-50. |
10 | Cheng L, Tan L, Zhang L, et al (2013). Chronic disease mortality in rural and urban residents in Hubei Province, China, 2008- 2010. BMC Public Health, 13, 713. DOI |
11 | Gao YT, Tu JT, Jin F, et al (1981). Cancer mortality in Shanghai during the period 1963-77. Br J Cancer, 43, 183-95. DOI |
12 | Gartner A, Farewell D, Roach P, et al (2011). Rural/urban mortality differences in England and Wales and the effect of deprivation adjustment. Soc Sci Med, 72, 1685-94. DOI |
13 | Guo P, Huang ZL, Yu P, et al (2012). Trends in cancer mortality in China: an update. Ann Oncol, 23, 2755-62. DOI |
14 | Hamra GB, Guha N, Cohen A, et al (2014). Outdoor particulate matter exposure and lung cancer: a systematic review and meta-analysis. Environ Health Persp, 22, 906-11. |
15 | Han R, Zheng R, Zhang S, et al (2013). Trend analyses on the differences of lung cancer incidence between gender, area and average age in China during 1989-2008. Zhongguo Fei Ai Za Zhi (Chin J Lung Can), 16, 445-51. |
16 | Hayat MJ, Howlader N, Reichman ME, et al (2007). Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist, 12, 20-37. DOI |
17 | Jung KW, Yim SH, Kong HJ, et al (2007). Cancer survival in Korea 1993-2002: a population-based study. J Korean Med Sci, 22, 5-10. DOI |
18 | Kachuri L, De P, Ellison LF, et al (2013). Cancer incidence, mortality and survival trends in Canada, 1970-2007. Chronic Dis Inj Can, 33, 69-80. |
19 | Li J, Song Q, Zhou X, et al (2011). Major cancer mortality and changes in Yanting, 2004-2009: introduction to cancer challenges in a high risk area. Asian Pac J Cancer Prev, 12, 409-13. |
20 | Mahesh PA, Archana S, Jayaraj BS, et al (2012). Factors affecting 30-month survival in lung cancer patients. Indian J Med Res, 136, 614-21. |
21 | Mao WM, ed (2013). Cancer Incidence and Mortality in Registration Areas in Zhejiang Province 200-2009. Hangzhou: Zhejiang University Press. 1-162. |
22 | Marugame T, Matsuda T (2009). Comparison of time trends in lung cancer incidence (1973-2002) in Asia, from cancer incidence in five continents Vols IV-IX. Jpn J Clin Oncol, 39, 133-5. |
23 | Nagakura H, Nishikawa M, Kusano N, et al (2012). The impact of a negative history of smoking on survival in patients with non-small cell lung cancer detected with clinic-based screening programs. Intern Med, 51, 3115-8. DOI |
24 | Parkin DM, Whelan SL, Ferlay J, et al (1997). Cancer Incidence in Five Continents, Vol. VII, IARC Sci Pub No. 143. Lyon:IARC. |
25 | Parkin DM, Whelan SL, Ferlay J, et al (2002). Cancer Incidence in Five Continents, Vol. VIII, IARC Sci Pub No. 155. Lyon:IARC. |
26 | Parkin DM (1994). Cancer in developing countries. Cancer Surv,19-20, 519-61. |
27 | Raaschou-Nielsen O, Andersen ZJ, Beelen R, et al (2013). Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol, 14, 813-22. DOI |
28 | Ridge CA, McErlean AM, Ginsberg MS (2013). Epidemiology of lung cancer. Semin Intervent Radiol, 30, 93-8. DOI |
29 | Roshandel G, Boreiri M, Sadjadi A, et al (2014). A diversity of cancer incidence and mortality in west Asian populations. Ann Glob Health, 80, 346-57. DOI |
30 | Sankaranarayanan R, Swaminathan R, eds (2011). Cancer Survival in Africa, Asia, the Caribbean and Central America. IARC Sci Publ No. 162, Lyon: IARC, 43-53. |
31 | Shin HR, Carlos MC, Varghese C (2012). Cancer control in the Asia Pacific region: current status and concerns. Jpn J Clin Oncol, 42, 867-81. DOI |
32 | Siegel R, Ma J, Zou Z, et al (2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9-29. DOI |
33 | Simard EP, Ward EM, Siegel R, et al (2012). Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin, 62, 118-28. DOI |
34 | Singh GK, Siahpush M, Williams SD (2012). Changing urbanization patterns in US lung cancer mortality, 1950-2007. J Community Health, 37, 412-20. DOI |
35 | Swerdlow AJ, dos Santos Silva I, Reid A, et al (1998). Trends in cancer incidence and mortality in Scotland: description and possible explanations. Br J Cancer, 77, 1-54. |
36 | Tsukuma H, Ajiki W, Ioka A, et al (2006). Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol, 36, 602-7. DOI |
37 | Varghese C, Carlos MC, Shin HR (2014). Cancer burden and control in the Western pacific region: challenges and opportunities. Ann Glob Health, 80, 358-69. DOI |
38 | Wang QJ, Zhu WX, Li L, et al (2001). Cancer Survival in Urban Beijing. Chin Cancer, 10, 263-4. |
39 | Wang QJ, Zhu WX (1990). Epidemiological features for lung cancer in Beijing. Chin J Cancer Res, 2, 49-51. DOI |
40 | Xiang YB, Jin F, Chen HQ, et al (1996). An analysis of tumor patients’ survival in Shanghai during 1988-1991. Chin Cancer, 5, 6-8. |
41 | Yang L, Parkin DM, Li LD, et al (2004). Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer, 90, 2157-66. |
42 | Yang L, Yuan Y, Sun T, et al (2015). Population-based cancer incidence analysis in Beijing, 2008-2012. Chin J Cancer Res, 7, 13-21. |
43 | Zeng HM, Zeng RS, Guo YM, et al (2015). Cancer survival in China, 2003-2005: A population-based study. Int J Cancer, 136, 1921-30. DOI |
44 | Zhao P, Chen WQ, Kong LZ (2012). Cancer Incidence and Mortality in China (2003-2007). Beijing: Military Medical Science Press. |
45 | Zhou Y, Cui Z, Zhou X, et al (2013). The presence of old pulmonary tuberculosis is an independent prognostic factor for squamous cell lung cancer survival. J Cardiothorac Surg, 8, 123. DOI |
46 | Allemani C, Weir HK, Carreira H, et al (2015). Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 populationbased registries in 67 countries (CONCORD-2). Lancet, 385, 977-1010. DOI |
47 | Berrino F, Sant M, Verdecchia A, eds (1995). Survival of cancer patients in Europe: the EUROCARE Study. IARC Sci Pub No, 132, 1-463. |
48 | Curado MP, Edwards B, Shin HR, et al (2009). Cancer Incidence in Five Continents. Vol IX. IARC Sci Pub No. 160. Lyon: IARC, 1-897. |
49 | De Angelis R, Sant M, Coleman MP, et al (2014). Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5: a population-based study. Lancet Oncol, 15, 23-34. DOI |
50 | Demetriou CA, Vineis P (2015). Carcinogenicity of ambient air pollution: use of biomarkers, lessons learnt and future directions. J Thorac Dis, 7, 67-95. |
51 | D'Souza ND, Murthy NS, Aras RY (2013). Projection of cancer incident cases for India -till 2026. Asian Pac J Cancer Prev, 14, 4379-86. DOI |
52 | Ferlay J, Soerjomataram I, Ervik M, et al (2015a): GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; Available from: http://globocan.iarc.fr. 18 May 2015. |
53 | Ferlay J, Soerjomataram I, Dikshit R, et al (2015b). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, 359-86. DOI |
54 | Finnish Cancer Registry. SURV3: Windows Software for Relative Survival Analysis, http://www.cancer.fi/@Bin/54321472/index.html, Accessed 25 May 2015. |
55 | Forman D, Bray F, Brewster DH, eds (2014). Cancer Incidence in Five Continents. Vol X. IARC Sci Pub No. 164. Lyon: IARC, 1-1435. |
56 | Forrest LF, Adams J, Wareham H,et al (2013). Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis. Plos Med, 10, e1001376. DOI |
57 | Gao YT, Lu W, eds (2007). Cancer Incidence, Mortality and Survival Rates in Urban Shanghai (1973-2000). Shanghai: Second Military Medical University Press, 1-443. |